Cost-effectiveness of treatments for presymptomatic newborn patients with spinal muscular atrophy and two or three copies of the survival motor neuron 2 gene in Italy Giugno 26, 2026
Cost-effectiveness analysis of lorlatinib as first-line treatment for anaplastic lymphoma kinase (ALK)-positive non–small cell lung cancer in Italy Aprile 27, 2026
Estensione del Programma di Screening Mammografico in Italia: Analisi Costo-Beneficio e Impatto della Diagnosi Precoce nelle Fasce d’Età 45-74 Anni Giugno 14, 2025
Budget impact of prophylactic treatment of rVIII-SingleChain in moderate and severe hemophilia A in Italy Febbraio 19, 2023
